As a result of successful events organised last year, a second Joint Scientific Forum, organised by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), two of the most respected professional medical organisations in Europe, will be held from 27-29 November at three venues across China - Beijing, Shanghai and Guangzhou.
The theme is the Optimal Management of Diabetes, with talks given to an audience of clinicians who treat diabetes and cardiology patients. Subjects to be covered include long-term efficacy for current treatment, early intervention and combination treatment for maximum benefit, Hyperglycaemia and Cardiovascular Disease (CVD), and Diabetic cardiopathy.
In recent years, the link between diabetes and heart disease has been the focus of international attention. Type 2 diabetes is one of the fastest growing public health problems in both developed and developing countries (1) and coronary heart disease (CHD) is the leading cause of death among patients with type 2 diabetes (2). Results from large-scale studies have raised questions on the safety of new diabetic drugs in connection with heart disease. At this forum, leading cardiologists and diabetologists will explore the concerns to be considered in the multidisciplinary management of diabetic patients and identify optimal treatment strategies for the Asian and European patient.